Pseudotumor Cerebri Syndrome with Resolution After Discontinuing High Vitamin A Containing Dietary Supplement: Case Report and Review

References

• Wall M. Idiopathic intracranial hypertension. Neurol Clin 2010;28(3):593–617. doi:10.1016/j.ncl.2010.03.003.
   PubMed Web of Science ®Google Scholar
• Friedman DI, Liu GT, Digre KB. Revised diagnostic criteria for the pseudotumor cerebri syndrome in adults and children. Neurology 2013;81:1159–1165. doi:10.1212/WNL.0b013e3182a55f17.
   PubMed Web of Science ®Google Scholar
• Friedman DI. The pseudotumor cerebri syndrome. Neurol Clin 2014;32:363–396. doi:10.1016/j.ncl.2014.01.001.
   PubMed Web of Science ®Google Scholar
• Markey KA, Mollan SP, Jensen RH, Sinclair AJ. Understanding idiopathic intracranial hypertension: mechanisms, management, and future directives. Lancet Neurol 2016;15:78–91. doi:10.1016/S1474-4422(15)00298-7.
   PubMed Web of Science ®Google Scholar
• Wakerley BR, Tan MH, Ting EY. Idiopathic intracranial hypertension. Cephalalgia 2015;35(3):248–261. doi:10.1177/0333102414534329.
   PubMed Web of Science ®Google Scholar
• Chen J, Wall M. Epidemiology and risk factors for idiopathic intracranial hypertension. Int Ophthalmol Clin 2014;54(1). doi:10.1097/IIO.0b013e3182aabf11.
   Google Scholar
• Mollan SP, Markey KA, Benzimra JD, Jacks A, Matthews TD, Burdon MA, Sinclair AJ. A practical approach to, diagnosis, assessment and management of idiopathic intracranial hypertension. Pract Neurol 2014;14:380–390. doi:10.1136/practneurol-2014-000821.
   PubMedGoogle Scholar
• Bruce BB, Kedar S, Van Stavern GP, Corbett JJ, Newman NJ, Biousse V. Atypical idiopathic intracranial hypertension. Neurology 2010;74:1827–1832. doi:10.1212/WNL.0b013e3181e0f838.
   PubMed Web of Science ®Google Scholar
• Johnson LN, Krohel GB, Madsen RW, March GA Jr. The role of weight loss and acetazolamide in the treatment of idiopathic intracranial hypertension (pseudotumor cerebri). Opthalmology 1998;105:2313–2317. doi:10.1016/S0161-6420(98)91234-9.
   PubMed Web of Science ®Google Scholar
• Kupersmith MJ, Gamell L, Turbin R, Peck V, Spiegel P, Wall M. Effects of weight loss on the course of idiopathic intracranial hypertension in women. Neurology 1998;50:1094–1098. doi:10.1212/WNL.50.4.1094.
   PubMed Web of Science ®Google Scholar
• Sinclair AJ, Burdon MA, Nightingale PG, Ball AK, Good P, Matthews TD, Jacks A, Lawden M, Clarke CE, Stewart PM, Walker EA, Tomlinson JW, Rauz S. Low energy diet and intracranial pressure in women with idiopathic intracranial hypertension: prospective cohort study. Bmj 2010;340:c2701. doi:10.1136/bmj.c2701.
   Web of Science ®Google Scholar
• Mollan SP, Ali F, Hassan-Smith G, Botfield H, Friedman DI, Sinclair AJ. Evolving evidence in adult idiopathic intracranial hypertension: pathophysiology and management. Neurol Neurosurg Psychiatry 2016;87:982–992. doi:10.1136/jnnp-2015-311302.
   PubMed Web of Science ®Google Scholar
• Subramaniam S, Fletcher WA. Obesity and weight loss in idiopathic intracranial hypertension: a narrative review. J Neuro-Ophthalmol 2016;0:1–9.
   Google Scholar
• Wall M, McDermott MP, Kieburtz KD, Corbett JJ, Feldon SE, Friedman DI, Keltner JL, Schron EB, Kupersmith MJ, NORDIC Idiopathic Intracranial Hypertension Study Group Writing Committee. Effect of acetazolamide on visual function in patients with idiopathic intracranial hypertension and mild visual loss: the idiopathic intracranial hypertension treatment trial. Jama 2014;311(16):1641–1651. doi:10.1001/jama.2014.3312.
   PubMed Web of Science ®Google Scholar
• Piper RJ, Kalyvas AV, Young AMH, Hughes MA, Jamjoom AAB, Fouyas IP. Interventions for idiopathic intracranial hypertension. Cochrane Database Syst Rev 2015;8: Art. No.: CD003434. doi:10.1002/14651858.CD003434.pub3.
   PubMed Web of Science ®Google Scholar
• Sirdofsky M, Kattah J, Macedo P. Intracranial hypertension in a dieting patient. J Neuro-Ophthalmol 1994;14(1):9–11. doi:10.1097/00041327-199403000-00004.
   PubMed Web of Science ®Google Scholar
• Friedman DI, Gordon LK, Egan RA, Jacobson DM, Pomeranz H, Harrison AR, Goldhammer Y. Doxycycline and intracranial hypertension. Neurology 2004;62:2297–2299. doi:10.1212/WNL.62.12.2297.
   PubMed Web of Science ®Google Scholar
• Friedman DI. Papilledema and idiopathic intracranial hypertension. Continuum (Minneap Minn) 2014;20(4):857–876.
   PubMedGoogle Scholar
• McGeeney BE, Friedman DI. Pseudotumor cerebri pathophysiology. Headache 2014;54:445–458. doi:10.1111/head.12291.
   PubMed Web of Science ®Google Scholar
• Jacobson DM, Berg R, Wall M, Digre KB, Corbett JJ, Ellefson RD. Serum vitamin A concentration is elevated in idiopathic intracranial hypertension. Neurology 1999;53(5):1114–1118. doi:10.1212/WNL.53.5.1114.
   PubMed Web of Science ®Google Scholar
• Warner JEA, Larson AJ, Bhosale P, Digre KB, Henley C, Alder SC, Katz BJ, Bernstein PS. Retinol-binding protein and retinol analysis in cerebrospinal fluid and serum of patients with and without idiopathic intracranial hypertension. J Neuro-Ophthalmol 2007;27:258–262. doi:10.1097/WNO.0b013e31815b9af0.
   PubMed Web of Science ®Google Scholar
• Warner JEA, Bernstein PS, Yemelyanov A, Alder SC, Farnsworth ST, Digre KB. Vitamin A in the cerebrospinal fluid of patients with and without idiopathic intracranial hypertension. Ann Neurol 2002;52:647–650. doi:10.1002/ana.10377.
   PubMed Web of Science ®Google Scholar
• Tabassi A, Salmasi AH, Jalali M. Serum and CSF vitamin A concentrations in idiopathic intracranial hypertension. Neurology 2005;64:1893–1896. doi:10.1212/01.WNL.0000163556.31080.98.
   PubMed Web of Science ®Google Scholar
• Selhorst JB, Kulkantrakorn K, Corbett JJ, Leira EC, Chung SM. Retinol-binding protein in idiopathic intracranial hypertension (IIH). J Neuro-Ophthalmol 2000;20(4):250–252. doi:10.1097/00041327-200020040-00009.
   PubMed Web of Science ®Google Scholar
• Gerber A, Raab AP, Sobei AE. Vitamin A poisoning in adults: with description of a case Amer J Med. 1954;16:729–745. doi:10.1016/0002-9343(54)90281-8.
   PubMed Web of Science ®Google Scholar
• Feldman MH, Schlezinger NS. Benign intracranial hypertension associated with hypervitaminosis A. Arch Neurol 1970;22:1–7. doi:10.1001/archneur.1970.00480190005001.
   PubMedGoogle Scholar
• Morrice G Jr., Havener WH, Kapetansky F. Vitamin A intoxication as a cause of pseudotumor cerebri. Jama 1960;173:1802–1805. doi:10.1001/jama.1960.03020340020005.
   PubMed Web of Science ®Google Scholar
• Libien J, Blaner WS. Retinol and retinol-binding protein in cerebrospinal fluid: can vitamin A take the “idiopathic” out of idiopathic intracranial hypertension? J Neuro-Ophthalmol 2007;27(4):253–257. doi:10.1097/WNO.0b013e31815c44bc.
   PubMed Web of Science ®Google Scholar
• Benzimra JD, Simon S, Sinclair AJ, Mollan SP. Sight-threatening pseudotumour cerebri associated with excess vitamin A supplementation. Pract Neurol 2015;15:72–73. doi:10.1136/practneurol-2014-000934.
   PubMedGoogle Scholar
• Marcus DF, Turgeon P, Aaberg TM, Wiznia RA, Wetzig PC, Bovino JA. Optic disk findings in hypervitaminosis A. Ann Ophthalmol 1985 Jul;17(7):397–402.
   PubMedGoogle Scholar
• Olson JA. Upper limits of vitamin A in infant formulas, with some comments on vitamin K. J Nutr 1989 Dec;119(12 Suppl):1820–1824.
   PubMed Web of Science ®Google Scholar
• Penniston KL, Tanumihardjo SA. The acute and chronic toxic effects of vitamin A. Am J Clin Nutr 2006;83:191–201.
   PubMed Web of Science ®Google Scholar
• Donahue SP. Recurrence of idiopathic intracranial hypertension after weight loss: the carrot craver. Am J Ophthalmol 2000;130:850–851. doi:10.1016/S0002-9394(00)00607-3.
   PubMed Web of Science ®Google Scholar
• Ko MW, Chang SC, Ridha MA, Ney JJ, Ali TF, Friedman DI, Mejico LJ, Volpe NJ, Galetta SL, Balcer LJ, Liu GT. Weight gain and recurrence in idiopathic intracranial hypertension. Neurology 2011;76:1564–1567. doi:10.1212/WNL.0b013e3182190f51.
   PubMed Web of Science ®Google Scholar